CIK 0001062822 · Non-accelerated filer<br>Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 760474169
- Phone
- 2818633000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-08 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Grant or award · Stock Option (Right to Buy) | +203,810 | 203,810 | ||
| 2024-02-08 | Granowitz Craig B SVP, Chief Medical Officer | Grant or award · Restricted Stock Units | +222,680 | 222,680 | ||
| 2024-02-08 | Granowitz Craig B SVP, Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +222,680 | 222,680 | ||
| 2024-02-08 | Garner Thomas SVP, Chief Commercial Officer | Grant or award · Restricted Stock Units | +227,130 | 227,130 | ||
| 2024-02-08 | Garner Thomas SVP, Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +227,130 | 227,130 |
Page 15 of 15 · 285 trades